HTL0022562

· Nxera Pharma UK Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HTL0022562, covering 2025-02-20 to 2025-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Subjects to Assess the Safety, Tolerability and Pharmacokinetics of HTL0022562 [Phase 1]